tirzepatide ketosis vs. Semaglutide: What You Should Know Tirzepatide: A First-in-class Twincretin for

The relative risk of cholelithiasis was 1.2, 1.3, and 1.4 in liraglutide, dulaglutide, and semaglutide with number needed to harm of 17.25, 14.69, and 10.96, respectively

Active Ingredient: Semaglutide 1.7 mg

The Indian drugmaker reported certain batches were out of specification due to an issue associated with the active pharmaceutical ingredient used in the product.

Overweight and obesity are increasingly common in adults with type 1 diabetes (T1D), contributing to insulin resistance, higher insulin requirements, and greater cardiometabolic burden

NEJM Editorial Fellow Harleen Marwah, MD, summarizes the SOUL trial

Weight loss having a negative effect on your face